Genetics/Genomics News

Bayer AG and its subsidiary Asklepios BioPharmaceutical announced the FDA granted fast track designation for its investigational gene therapy for the treatment of congestive heart failure.

Aortic stiffness, a known risk factor for cardiovascular disease, was raised among patients with alpha-1 antitrypsin deficiency vs. patients with COPD or healthy individuals, according to study results.

The 2024 American College of Cardiology Scientific Session will be held live in Atlanta from April 6 to 8 and virtually, with 43 late-breaking trials and featured clinical research presentations.

Regeneron Pharmaceuticals announced the FDA extended its approval of alirocumab as an adjunct to diet and other LDL-lowering therapies to include patients aged 8 years and older with heterozygous familial hypercholesterolemia.

Pharmacists are one of the most accessible health care providers and singularly well positioned to lead efforts in integrating pharmacogenomics testing to improve medication-related outcomes.

The elevated propensity for peripheral artery disease in patients with major depression may be mediated by increased liability for lifetime smoking and BMI, according to research in the Journal of the American Heart Association.

Sudden death from cardiac causes is among the leading causes of death in the United States, yet predicting who might be at high risk remains a difficult task.

Researchers reported that high concentrations of common genetic variants within families were associated with increased inherited risk for spontaneous coronary artery dissection.

Small HDL particles play a significant role in the prevention of Alzheimer’s disease, and an inherited gene present in one in four people hinders its production in the brain, increasing risk for cognitive decline, a speaker reported.

PHILADELPHIA — In this Healio video exclusive, Michael C. Honigberg, MD, MPP, discusses the latest research on clonal hematopoiesis of indeterminate potential in blood cells, an emerging risk factor for CVD.